Insider · CIK 0001601797
Eric Sullivan
Files at TCRR (TCR2 THERAPEUTICS INC.). First filing -, latest -.
In brief
Eric Sullivan files SEC Form 4 as CFO at TCRR (TCR2 THERAPEUTICS INC.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Eric Sullivan has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 5 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 1, 2023 | TCRR TCR2 THERAPEUTICS INC. | DDisposition to issuer Stock Option (Right to Buy)derivative | -40,820 | $0.00 | $0 | 0 | Jun 1, 2023 |
| Jun 1, 2023 | TCRR TCR2 THERAPEUTICS INC. | DDisposition to issuer Stock Option (Right to Buy)derivative | -250,000 | $0.00 | $0 | 0 | Jun 1, 2023 |
| Jun 1, 2023 | TCRR TCR2 THERAPEUTICS INC. | DDisposition to issuer Restricted Stock Unitderivative | -6,804 | $0.00 | $0 | 0 | Jun 1, 2023 |
| Dec 15, 2022 | TCRR TCR2 THERAPEUTICS INC. | AGrant or award Stock Option (Right to Buy)derivative | +40,820 | $0.00 | $0 | 40,820 | Dec 19, 2022 |
| Dec 15, 2022 | TCRR TCR2 THERAPEUTICS INC. | AGrant or award Restricted Stock Unit (Right to Buy)derivative | +6,804 | $0.00 | $0 | 6,804 | Dec 19, 2022 |
Questions about Eric Sullivan
Answered from the filings on this page, as of the latest one.
Is Eric Sullivan buying or selling?
Eric Sullivan has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Eric Sullivan's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Eric Sullivan has 0.
Where does Eric Sullivan file Form 4?
Eric Sullivan has filed Form 4 at TCRR (TCR2 THERAPEUTICS INC.) as Chief Financial Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.